【Abstract】 Background and objective The immune function disorder relates closely to the occurrence, metastasis, and prognosis of cancer. T lymphocyte subsets take an important role in immune function. We identified the dynamic changes of the immune system by investigating the levels of T lymphocyte subsets in peripheral blood of lung cancer patients with advanced stage adenocarcinoma undergoing first line chemotherapy. The results aided the search for rational chemoimmunotherapy strategies in lung cancer treatment. Methods Samples from 49 patients with pathologically demonstrated advanced stage adenocarcinoma cell lung cancer were compared with those from 33 healthy donors. Subsequently, the patients were separately treated with Docetaxol-based or Pemetrexed-based therapy. Peripheral blood samples at different time points after therapy were analyzed by flowcytometry. The lymphocyte subsets of the total lymphocytes were compared. Independent sample t test was used for the quantitative data analysis. Results The percentage of CD3 + , CD3 + CD4 + , CD4 + CD25 + cells of the lung cancer patients significantly varied from those of the healthy donors, the P values are 0.012, 0.034 and 0.006 separately.
·165· 中 国 肺 癌 杂 志 2 0 1 2 年 3 月 第 1 5 卷 第 3 期 Chin J Lung Cancer, March 2012, Vol. 15, No.3 enocarcinoma cell lung cancer patients was evidently suppressed, and was restored at the 4 th day, followed by a reduction at the 21 st day after chemotherapy. On the 4 th day, Pemetrexed showed better effect on the immune system. 
